Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity:

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.

Authors:

Robert E.J. Ryder, Katharina Laubner, Marek Benes, Martin Haluzik, Lynne Munro, Harry Frydenberg, Julian P. Teare, Aruchana Ruban, Sigal Fishman, Erwin Santo, Rainer Stengel, Charlotte De Jonge, Jan W. Greve, Ricardo V. Cohen, Cristina M. Aboud, Gerald J. Holtmann, Graeme Rich, Jess J. McMaster, Tadej Battelino,Primoz Kotnik, James P. Byrne, John C. Mason, Justin Bessell, Jeanine Bascomb,21 Lillian Kow, Janes Collins, Jacob Chisholm, Peter N. Pferschy, Harald Sourij, Melissa L. Cull, Melanie C. Wyres, Russell Drummond, Barbara McGowan, Stephanie A. Amiel, Mahi Yadagiri, Piya Sen Gupta, Jens Aberle, and Jochen Seufert.